Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel antibacterial carbapenems prepared and tested at Sumitomo

Dec. 23, 2004

Scientists at Millennium claim beta-carboline compounds

Dec. 23, 2004

Glutamate receptor modulators described in patent literature

Dec. 23, 2004

Two series of Tie-2 modulators claimed by Exelixis

Dec. 23, 2004

CB1 receptor antagonists described by Pfizer

Dec. 23, 2004

AxyS (Celera Genomics) researchers prepare and test HDAC inhibitors for leukemia

Dec. 22, 2004

Two series of p38 MAP kinase inhibitors described in patent literature

Dec. 22, 2004

New patent application covers antidiabetic agents

Dec. 22, 2004

Three patents covering 5-HT4 receptor modulators filed by Dainippon

Dec. 22, 2004

Ono discloses chemokine receptor ligands

Dec. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...